<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Recurrence after Hospitalization for Acute Coronary Syndrome among HIV-Infected and HIV-Uninfected Individuals</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2020-01-01">2020 January 01.</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><roleName>PhD, MPH</roleName><forename type="first">Julia</forename><forename type="middle">L</forename><surname>Marcus</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Harvard Medical School</orgName>
								<orgName type="institution">Harvard Pilgrim Health Care Institute</orgName>
								<address>
									<settlement>Boston</settlement>
									<region>MA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MPH</roleName><forename type="first">Leo</forename><forename type="middle">B</forename><surname>Hurley</surname></persName>
							<affiliation key="aff1">
								<orgName type="institution">Kaiser Permanente Division of Research</orgName>
								<address>
									<settlement>Oakland</settlement>
									<region>CA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD, MBA</roleName><forename type="first">Amit</forename><surname>Prasad</surname></persName>
							<affiliation key="aff2">
								<orgName type="institution">Kaiser Permanente San Francisco Medical Center</orgName>
								<address>
									<settlement>San Francisco</settlement>
									<region>CA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Jonathan</forename><surname>Zaroff</surname></persName>
							<affiliation key="aff2">
								<orgName type="institution">Kaiser Permanente San Francisco Medical Center</orgName>
								<address>
									<settlement>San Francisco</settlement>
									<region>CA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Daniel</forename><forename type="middle">B</forename><surname>Klein</surname></persName>
							<affiliation key="aff3">
								<orgName type="institution">Kaiser Permanente San Leandro Medical Center</orgName>
								<address>
									<settlement>San Leandro</settlement>
									<region>CA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD, MAS</roleName><forename type="first">Michael</forename><forename type="middle">A</forename><surname>Horberg</surname></persName>
							<affiliation key="aff4">
								<orgName type="institution">Kaiser Permanente Mid-Atlantic Permanente Research Institute</orgName>
								<address>
									<settlement>Rockville</settlement>
									<region>MD</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Alan</forename><forename type="middle">S</forename><surname>Go</surname></persName>
							<affiliation key="aff1">
								<orgName type="institution">Kaiser Permanente Division of Research</orgName>
								<address>
									<settlement>Oakland</settlement>
									<region>CA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Gerald</forename><forename type="middle">N</forename><surname>Delorenze</surname></persName>
							<affiliation key="aff1">
								<orgName type="institution">Kaiser Permanente Division of Research</orgName>
								<address>
									<settlement>Oakland</settlement>
									<region>CA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Charles</forename><forename type="middle">P</forename><surname>Quesenberry</surname><genName>Jr</genName></persName>
							<affiliation key="aff1">
								<orgName type="institution">Kaiser Permanente Division of Research</orgName>
								<address>
									<settlement>Oakland</settlement>
									<region>CA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD, MPH</roleName><forename type="first">Stephen</forename><surname>Sidney</surname></persName>
							<affiliation key="aff1">
								<orgName type="institution">Kaiser Permanente Division of Research</orgName>
								<address>
									<settlement>Oakland</settlement>
									<region>CA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Joan</forename><forename type="middle">C</forename><surname>Lo</surname></persName>
						</author>
						<author role="corresp">
							<persName><roleName>PhD, MPH</roleName><forename type="first">Michael</forename><forename type="middle">J</forename><surname>Silverberg</surname></persName>
							<email>michael.j.silverberg@kp.org</email>
							<affiliation key="aff1">
								<orgName type="institution">Kaiser Permanente Division of Research</orgName>
								<address>
									<settlement>Oakland</settlement>
									<region>CA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="institution">Kaiser Permanente Division of Research</orgName>
								<address>
									<settlement>Oakland</settlement>
									<region>CA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff5">
								<orgName type="institution">MPH</orgName>
								<address>
									<postCode>2000, 94612</postCode>
									<settlement>Broadway, Oakland</settlement>
									<region>CA</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff6">
								<orgName type="institution">St. Luke&apos;s University Health Network</orgName>
								<address>
									<settlement>Phillipsburg</settlement>
									<region>NJ</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Recurrence after Hospitalization for Acute Coronary Syndrome among HIV-Infected and HIV-Uninfected Individuals</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2020-01-01">2020 January 01.</date>
						</imprint>
					</monogr>
					<idno type="MD5">42E2EE358D53BFEA94772966867600AE</idno>
					<idno type="DOI">10.1111/hiv.12670</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:47+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>HIV</term>
					<term>acute coronary syndrome</term>
					<term>myocardial infarction</term>
					<term>cardiovascular diseases</term>
					<term>CD4 lymphocyte count Recent CD4 cells/μL (HIV-uninfected reference) &lt;200 200-499 ≥500 ACS, acute coronary syndrome</term>
					<term>STEMI, ST elevation myocardial infarction</term>
					<term>NSTEMI, non-ST elevation myocardial Recent CD4 cells/μL (HIV-uninfected reference) &lt;200 200-499 ≥500 ACS, acute coronary syndrome</term>
					<term>STEMI, ST elevation myocardial infarction</term>
					<term>NSTEMI, non-ST elevation myocardial</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Objectives.-We evaluated the association of HIV infection and immunodeficiency with acute coronary syndrome (ACS) recurrence, and with all-cause mortality as a secondary outcome, after hospitalization for ACS among HIV-infected and HIV-uninfected individuals.</s></p><p><s>Methods.-We conducted a retrospective cohort study within Kaiser Permanente Northern California of HIV-infected and HIV-uninfected adults discharged after ACS hospitalization (types: ST elevation myocardial infarction [STEMI], non-STEMI, or unstable angina) during 1996-2010.</s><s>We compared the outcomes of ACS recurrence and all-cause mortality within three years, both overall by HIV status and stratified by recent CD4 count, with HIV-uninfected individuals as the reference group.</s><s>Hazard ratios (HRs) were obtained from Cox regression models with adjustment for age, sex, race/ethnicity, year, ACS type, smoking, and cardiovascular risk factors.</s></p><p><s>Results.-Among 226 HIV-infected and 86,321 HIV-uninfected individuals with ACS, HIVinfected individuals had a similar risk of ACS recurrence compared with HIV-uninfected individuals (HR 1.08, 95% confidence interval [CI]: 0.76-1.54).</s><s>HIV infection was independently associated with all-cause mortality after ACS hospitalization overall (HR 2.52, 95% CI: 1.81-3.52).</s><s>In CD4-stratified models, post-ACS mortality was higher for HIV-infected individuals with CD4 201-499 cells/μL (HR 2.64, 95% CI: 1.66-4.20)</s><s>and &lt;200 cells/μL (HR 5.41, 95% CI: 3.14-9.34),</s><s>but not those with ≥500 cells/μL (HR 0.67, 95% CI: 0.22-2.08),</s><s>compared with HIVuninfected individuals (P trend &lt;0.001).</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>INTRODUCTION</head><p><s>Antiretroviral therapy use in developed countries has dramatically improved the life expectancy of individuals with human immunodeficiency virus (HIV) infection.</s><s><ref type="bibr" target="#b0">(1,</ref><ref type="bibr" target="#b1">2)</ref> As a result, medical care for HIV-infected patients is increasingly focused on non-AIDS-related morbidity, with a particularly high burden of cardiovascular disease in this population.</s><s>Compared with HIV-uninfected individuals, HIV patients have a 30-80% higher risk of acute coronary syndrome (ACS), including myocardial infarction (MI).</s><s><ref type="bibr" target="#b2">(3)</ref><ref type="bibr" target="#b3">(4)</ref><ref type="bibr" target="#b4">(5)</ref><ref type="bibr" target="#b5">(6)</ref><ref type="bibr" target="#b6">(7)</ref><ref type="bibr" target="#b7">(8)</ref><ref type="bibr" target="#b8">(9)</ref> This excess risk may be attributable to chronic inflammation and immunodeficiency in the setting of HIV infection, <ref type="bibr" target="#b6">(7,</ref><ref type="bibr" target="#b9">10)</ref> toxicity from antiretroviral medications, <ref type="bibr" target="#b10">(11,</ref><ref type="bibr" target="#b11">12)</ref> or the higher prevalence of cardiovascular risk factors among HIV-infected individuals.</s><s><ref type="bibr" target="#b12">(13,</ref><ref type="bibr" target="#b13">14)</ref> Although the excess risk of cardiovascular disease among HIV patients has diminished in recent years in our study setting, <ref type="bibr" target="#b14">(15)</ref> the impact of HIV infection on ACS prognosis remains unclear.</s></p><p><s>Prior studies of ACS that included an HIV-uninfected comparison group have found that HIV-infected patients with ACS present at a younger age and, in some cases, with a higher prevalence of traditional coronary risk factors such as smoking and dyslipidemia.</s><s><ref type="bibr" target="#b15">(16)</ref><ref type="bibr" target="#b16">(17)</ref><ref type="bibr" target="#b17">(18)</ref><ref type="bibr" target="#b18">(19)</ref><ref type="bibr" target="#b19">(20)</ref><ref type="bibr" target="#b20">(21)</ref> However, few prior studies have had sufficient sample size to account for the role of coronary risk factors in ACS outcomes by HIV status.</s><s>Furthermore, because HIV-associated immunodeficiency is linked to risk of primary MIs, HIV patients diagnosed with ACS at low CD4 cell counts may have poorer prognosis, but previous studies have not assessed immunodeficiency as a risk factor for recurrent ACS or mortality.</s></p><p><s>In this study, we evaluated the association of HIV infection and immunodeficiency with ACS recurrence after hospitalization for ACS among HIV-infected and HIV-uninfected individuals within a large integrated healthcare system, accounting for traditional coronary risk factors.</s><s>As a secondary outcome, we also assessed all-cause mortality after hospitalization for ACS among HIV-infected and HIV-uninfected individuals.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>METHODS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Study Design, Setting, and Population</head><p><s>We conducted a retrospective cohort study of HIV-infected and HIV-uninfected individuals who were members of Kaiser Permanente (KP) Northern California, a large integrated healthcare system providing comprehensive medical services to 4.1 million members, corresponding to approximately one-third of insured individuals in the surrounding population.</s><s><ref type="bibr" target="#b21">(22)</ref> Our study population included adults (≥18 years of age) who were KP members during 1996-2010, and who survived a hospital admission for ACS (i.e., ST elevation myocardial infarction [STEMI], non-STEMI, or unstable angina).</s></p><p><s>Hospitalizations for ACS were identified using KP's electronic health record (EHR) and defined as a primary discharge diagnosis of acute MI (International Classification of Disease codes, version 9 [ICD-9]: 410x) or unstable angina (ICD-9: 411.x), with MI diagnoses further classified as STEMI (ICD-9: 410.0-410.6,</s><s>410.8) or NSTEMI (ICD-9: 410.7, 410.9), using combinations of codes that were previously shown to have a positive predictive value of 97% for any MI, 79% for STEMI, and 91% for NSTEMI in the general population at KP. <ref type="bibr" target="#b22">(23)</ref> HIV-infected individuals were identified using a KP HIV registry that includes all known cases of HIV/AIDS since the early 1980s, with HIV-infected status confirmed by review of medical charts or medical center case lists.</s><s>Subjects were followed from the first ACS hospitalization at KP until the earliest of ACS recurrence, death, health plan disenrollment, three years after discharge, or December 31, 2010.</s><s>For recurrence analyses, the start of follow-up was seven days after discharge to exclude readmissions that were likely associated with the initial ACS event; for mortality analyses, the start of follow-up was ACS hospital discharge.</s></p><p><s>The institutional review board at KP Northern California approved this study with a waiver of written informed consent.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Study Measurements</head><p><s>The primary exposures were HIV infection and immunodeficiency, obtained from the KP HIV registry and CD4 test results, respectively.</s><s>The primary outcome was recurrent ACS, and the secondary outcome was death from any cause, both assessed within three years of initial hospitalization for ACS.</s><s>Recurrent ACS was ascertained using the same definition as described for primary ACS events.</s><s>In addition to KP's EHR, deaths from all causes were ascertained from California death certificates <ref type="bibr" target="#b23">(24)</ref> and Social Security Administration datasets.</s><s><ref type="bibr" target="#b24">(25)</ref> Other data extracted from the EHR included age; race/ethnicity; health plan enrollment periods; laboratory data (i.e., CD4 T-cell counts, high-density lipoprotein [HDL] and low-density lipoprotein [LDL] cholesterol, and triglycerides); pharmacy data (i.e., ART use, statin use); and clinical diagnoses of smoking/tobacco use (ICD-9: 305.1, V15, V65, 649, internal social history codes) and hypertension (ICD-9: 401.xx).</s><s>Diabetes status was ascertained from the KP Northern California diabetes registry.(</s><s><ref type="formula">26</ref>)</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistical Analysis</head><p><s>We first compared characteristics of HIV-infected and HIV-uninfected ACS cases, using chisquare tests for categorical variables and t-tests for continuous variables.</s><s>We then compared ACS recurrence and all-cause mortality within three years after ACS hospitalization using Kaplan-Meier curves and log-rank tests, both overall for HIV status and stratified by age, with HIV-uninfected individuals as the reference group.</s><s>Unadjusted and adjusted hazard ratios (HRs) for ACS recurrence and mortality were obtained from Cox regression models comparing HIV-infected with HIV-uninfected individuals, overall and stratified by ACS type and the most recent CD4 count in the six months prior to ACS hospitalization, using likelihood-ratio tests for trends across strata of CD4 count.</s><s>We also used adjusted Cox models to identify risk factors for ACS recurrence.</s><s>Adjusted models included terms for age, sex, race/ethnicity (white, black, other), ACS hospitalization year, ACS type (STEMI, NSTEMI, unstable angina), smoking (ever/never), LDL (≥160, &lt;160 mg/dl) and HDL cholesterol (&lt;40, ≥40 mg/dl), triglycerides (&lt;150, ≥150 mg/dl), statin use in the year prior to ACS hospitalization (yes/no), hypertension in the year prior to ACS hospitalization (yes/no), and history of diabetes prior to ACS hospitalization (yes/no).</s><s>Models in the HIV-infected subset additionally included most recent CD4 cells/μL in the six months prior to first ACS hospitalization (&lt;200, 200-499, ≥500) and current ART use at the time of first ACS hospitalization (none, protease inhibitor-based, protease inhibitor-sparing).</s></p><p><s>Analyses were conducted in SAS 9.3 (Cary, North Carolina, USA).</s><s>Statistical tests were two-sided, and statistical significance was defined as P&lt;0.05.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>RESULTS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Study Population</head><p><s>We identified 229 HIV-infected and 91,281 HIV-uninfected individuals with a hospitalization for ACS, of whom 3 (1.3%) and 4,960 (5.4%) died during hospitalization, respectively.</s><s>The study population included the 226 HIV-infected and 86,321 HIVuninfected individuals who survived until hospital discharge (Table <ref type="table" target="#tab_0">1</ref>).</s><s>Compared with HIVuninfected individuals, HIV-infected individuals were younger and more were male.</s><s>The distribution of ACS type differed by HIV status, with a higher proportion of HIV-infected individuals admitted with STEMI and a lower proportion with unstable angina compared with HIV-uninfected individuals.</s><s>A higher proportion of HIV patients had a history of smoking, HDL cholesterol &lt;40 mg/dl, and triglycerides ≥150 mg/dl, whereas a lower proportion had hypertension or diabetes.</s><s>LDL cholesterol and statin use were similar by HIV status.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Recurrence after ACS</head><p><s>Among the 226 HIV-infected and 86,242 HIV-uninfected subjects with at least seven days of follow-up after ACS hospitalization, the cumulative incidence of ACS recurrence was similar for HIV-infected compared with HIV-uninfected individuals overall (15% vs. 16%, P=0.42) and among those aged &lt;60, 60-64, or ≥65 years (Figure <ref type="figure" target="#fig_0">1</ref>).</s></p><p><s>In unadjusted Cox regression models, ACS recurrence did not differ by HIV status overall or in models stratified by ACS type and CD4 count (Table <ref type="table">2</ref>).</s><s>After adjustment for demographic and cardiovascular risk factors, HIV-infected individuals had a similar risk of ACS recurrence compared with HIV-uninfected individuals overall (HR 1.08, 95% CI: 0.76-1.54),</s><s>and there was no increased risk of ACS recurrence among HIV-infected individuals with STEMI, NSTEMI, or unstable angina.</s><s>In adjusted models, ACS recurrence did not differ between HIV-infected individuals with CD4 ≥500 cells/μL (HR 0.82, 95% CI: 0.39-1.73),</s><s>those with CD4 201-499 cells/μL (HR 1.14, 95% CI: 0.69-1.90),</s><s>or those with CD4 &lt;200 cells/μL (HR 1.42, 95% CI: 0.74-2.72)</s><s>compared with HIV-uninfected individuals (P trend = 0.36).</s></p><p><s>In adjusted models among HIV-infected individuals, only smoking was associated with a higher risk of ACS recurrence (HR 3.52, 95% CI: 1.61-7.72).</s><s>Among HIV-uninfected individuals, each additional year of age (HR 1.10, 95% CI: 1.09-1.12),</s><s>NSTEMI compared with unstable angina (HR 1.08, 95% CI: 1.03-1.12),</s><s>HDL cholesterol &lt;40 mg/dl (HR 1.08, 95% CI: 1.04-1.13),</s><s>statin use (HR 1.27, 95% CI: 1.22-1.32),</s><s>hypertension (HR 1.13, 95% CI: 1.08-1.18),</s><s>and diabetes (HR 1.34, 95% CI: 1.30-1.39)</s><s>were associated with an increased risk of ACS recurrence, while increasing year of initial ACS hospitalization was associated with reduced risk of recurrence (HR 0.94, 95% CI: 0.93-0.94).</s><s>Sex, smoking, and LDL cholesterol were not associated with ACS recurrence among HIV-uninfected individuals.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>All-Cause Mortality after ACS</head><p><s>Among the 226 HIV-infected and 86,321 HIV-uninfected subjects discharged after an ACS hospitalization, there was no difference in all-cause mortality for HIV-infected compared with HIV-uninfected individuals overall (17% vs. 19%, P=0.43).</s><s>However, in age-stratified analysis, mortality was higher for HIV-infected compared with HIV-uninfected individuals who were aged &lt;60 (12% vs. 5.1%, P&lt;0.001) and 60-64 years (19% vs. 9.1%, P=0.022), and numerically but not statistically higher for those aged ≥65 years (39% vs. 28%, P=0.23; Figure <ref type="figure" target="#fig_1">2</ref>).</s><s>Of the 35 HIV-infected individuals who died in the three years after ACS hospitalization, 34 had a known cause of death; of those, 14 (41%) were attributable to HIV infection, 12 (35%) to cardiovascular disease, and the remaining 8 (24%) to other causes.</s></p><p><s>In unadjusted Cox regression models, all-cause mortality within three years after ACS hospitalization did not differ by HIV status overall or for any ACS types (Table <ref type="table">3</ref>).</s><s>In adjusted models, HIV-infected individuals had an over twofold higher risk of death compared with HIV-uninfected individuals (HR 2.52, 95% CI: 1.81-3.52),</s><s>with similar results for STEMI, NSTEMI, and unstable angina.</s><s>In unadjusted CD4-stratified models, mortality was lower for HIV-infected individuals with CD4 ≥500 cells/μL, and higher for those with CD4 &lt;200 cells/μL, compared with HIV-uninfected individuals.</s><s>After adjustment, mortality was similar for HIV-infected individuals with CD4 ≥500 cells/μL (HR 0.67, 95% CI: 0.22-2.08),</s><s>but elevated for those with CD4 201-499 cells/μL (HR 2.64, 95% CI: 1.66-4.20)</s><s>and those with &lt;200 cells/μL (HR 5.41, 95% CI: 3.14-9.34)</s><s>compared with HIVuninfected individuals (P trend &lt;0.001).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>DISCUSSION</head><p><s>In this large observational study of HIV-infected and HIV-uninfected adults hospitalized for ACS within the same healthcare system, HIV infection was not associated with ACS recurrence within three years, even after adjustment for demographic characteristics and cardiovascular risk factors.</s><s>We also found no association between CD4 count and ACS recurrence.</s><s>HIV infection was independently associated with an over twofold higher risk of all-cause mortality within three years after ACS hospitalization, but HIV-infected individuals with recent CD4 ≥500 cells/μL had a similar prognosis after ACS compared with HIVuninfected individuals.</s></p><p><s>We found that HIV infection was not associated with an increased risk of ACS recurrence after initial ACS hospitalization.</s><s>Prior studies of ACS outcomes that included both HIV patients and an HIV-uninfected comparison group have had mixed results.</s><s>Two small matched studies of HIV-infected and HIV-uninfected patients with ACS, conducted in 2003 and 2004, found a higher risk of recurrent events and clinical restenosis in HIV patients, <ref type="bibr" target="#b15">(16,</ref><ref type="bibr" target="#b16">17)</ref> while more recent and larger studies found no difference in recurrent events by HIV status <ref type="bibr" target="#b18">(19,</ref><ref type="bibr" target="#b19">20)</ref>.</s><s>Boccara et al. found an increased risk of recurrence in the HIV-infected group within one year; however, this study did not find a difference by HIV status in major adverse cardiac and cerebral events, a composite outcome that included ACS recurrence.</s><s><ref type="bibr" target="#b17">(18)</ref> Similarly, Lorgis et al. found an increased risk of hospitalization for heart failure for HIV patients in the first year after acute MI, but no difference in recurrence by HIV status.</s><s><ref type="bibr" target="#b26">(27)</ref> Findings on ACS recurrence by HIV status may vary across studies because of heterogeneity in study populations, the distribution of confounders, or analytic approaches.</s><s>Findings may also vary over time, as antiretroviral therapy for HIV patients has become more lipidfriendly and the incidence of primary MIs in this population has decreased relative to HIVuninfected individuals.(</s><s><ref type="formula">15</ref>) Finally, similar to findings by Calvo-Sanchez et al., <ref type="bibr" target="#b27">(28)</ref> we found that smoking was a strong predictor of ACS recurrence for HIV-infected but not HIVuninfected individuals, highlighting the need for smoking cessation strategies in the HIV patient population.</s></p><p><s>Immunodeficiency has been linked to incident MIs in HIV-infected individuals, <ref type="bibr" target="#b8">(9,</ref><ref type="bibr" target="#b28">(29)</ref><ref type="bibr" target="#b29">(30)</ref><ref type="bibr" target="#b30">(31)</ref> including in our own study population, <ref type="bibr" target="#b6">(7)</ref> an association that may reflect the role of chronic inflammation in the development of atherosclerosis.(</s><s><ref type="formula">10</ref>) Here, we build on our prior work by demonstrating that HIV-infected individuals have an increased risk of all-cause mortality but not ACS recurrence at lower CD4 counts.</s><s>Indeed, the excess risk of mortality for HIVinfected individuals in our study was specific to those with lower CD4 counts, suggesting that HIV patients with more preserved immune function have similar prognosis after initial ACS hospitalization to HIV-uninfected individuals.</s><s>Although 35% of deaths among HIV patients in our study were attributable to cardiovascular causes, we were unable to assess cause of death in the HIV-uninfected patients.</s><s>Thus, we could not directly evaluate the relationship between ACS and mortality by HIV status.</s></p><p><s>There are several limitations to our study.</s><s>First, given the large number of cases, we relied on ICD-9 codes to identify ACS diagnoses, and this may have resulted in some misclassification.</s><s>The ideal approach would have been prospective adjudication of events, similar to other HIV cohort studies.(32)</s><s>However, we used combinations of codes that were previously validated for identification of acute MIs at KP; <ref type="bibr" target="#b22">(23)</ref> furthermore, although cardiac enzyme data were not used in our definition of an MI, an MI discharge diagnosis is made at KP only after troponin and/or CK-MB confirmation.</s><s>Finally, any misclassification is likely to have been non-differential by HIV status.</s><s>Second, because a substantial proportion of deaths in the HIV-infected group were attributable to HIV infection, future studies should assess post-ACS outcomes by HIV status using cause-specific mortality data.</s><s>Third, most of the HIV-infected subjects were men, reflecting the epidemiology of the HIV epidemic in California; this may limit the generalizability of our results to women.</s><s>Fourth, the relatively small number of HIV-infected individuals resulted in wide confidence intervals in analyses stratified by ACS type and CD4 count, as well as analyses to identify risk factors for recurrence and mortality among HIV patients.</s><s>Fifth, we did not include data on postdischarge medications or procedures, such as percutaneous coronary intervention or coronary artery bypass grafting, which may differ by HIV status; however, given that HIV patients with MI may be treated less aggressively, <ref type="bibr" target="#b32">(33)</ref> our results are likely conservative.</s><s>Finally, although our analyses included several traditional cardiovascular risk factors, we were not able to assess the role of substance use or specific antiretroviral therapy regimens in risk for ACS recurrence.</s></p><p><s>Our study also has several strengths.</s><s>First, few others have compared ACS outcomes between HIV-infected and HIV-uninfected individuals from the same healthcare system.</s><s>Such an approach reduced the likelihood of selection bias and minimized the impact of potential differences by HIV status in access to care.</s><s>Second, we expand on the existing literature by investigating the role of CD4 count in ACS outcomes, with results suggesting that immunodeficiency was not associated with ACS recurrence, and that HIV-infected individuals with well-controlled infection have comparable mortality after ACS hospitalization to that of the general population.</s><s>Third, our analyses accounted for key confounders, including history of smoking, levels of LDL, HDL, and triglycerides, statin use, hypertension, and diabetes.</s><s>Finally, the KP membership mirrors the age, sex, and race/ ethnicity distributions of the California population, <ref type="bibr" target="#b21">(22)</ref> and the demographics of HIVinfected members are comparable to those of reported AIDS cases in California.(34)</s><s>Thus, our results are likely to be generalizable to the broader insured population.</s></p><p><s>In summary, our study found a similar three-year risk of ACS recurrence between HIVinfected and HIV-uninfected individuals hospitalized for ACS.</s><s>HIV-infected individuals had over double the risk of all-cause mortality within three years after ACS hospitalization, but HIV patients with high CD4 counts were not at increased risk of death compared to HIVuninfected individuals.</s><s>Our findings suggest that HIV patients do not have an excess risk of ACS recurrence regardless of their level of immunodeficiency.</s><s>Future studies should evaluate the association of HIV infection and immunodeficiency with cardiovascularspecific mortality after ACS.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Characteristics of HIV-infected and HIV-uninfected individuals at the time of first hospitalization for ACS</head></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 1 .</head><label>1</label><figDesc><div><p><s>Figure 1.</s><s>Cumulative incidence of recurrent ACS within three years after ACS hospitalization, by HIV status overall and stratified by age.</s><s>ACS, acute coronary syndrome; HIV, human immunodeficiency virus.</s><s>P-values obtained from log-rank tests.</s></p></div></figDesc><graphic coords="10,84.00,62.00,504.00,252.00" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Figure 2 .</head><label>2</label><figDesc><div><p><s>Figure 2. Cumulative incidence of all-cause mortality within three years after ACS hospitalization, by HIV status overall and stratified by age.</s><s>ACS, acute coronary syndrome; HIV, human immunodeficiency virus.</s><s>P-values obtained from log-rank tests.</s></p></div></figDesc><graphic coords="11,84.00,62.00,504.00,252.00" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1 .</head><label>1</label><figDesc></figDesc><table /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>HIV-infected (n=226) HIV-uninfected (n=86,321) P-value</head><label></label><figDesc><div><p><s>ACS, acute coronary syndrome; SD, standard deviation; STEMI, ST elevation myocardial infarction; NSTEMI, non-ST elevation myocardial infarction.</s><s>P-values obtained from chi-square tests for categorical variables and t-tests for continuous variables.</s></p></div></figDesc><table><row><cell>Age in years, mean (SD)</cell><cell>54 (9.3)</cell><cell>67 (13)</cell><cell>&lt;0.001</cell></row><row><cell>Male, %</cell><cell>94</cell><cell>63</cell><cell>&lt;0.001</cell></row><row><cell>Race/ethnicity, % of known</cell><cell></cell><cell></cell><cell>&lt;0.001</cell></row><row><cell>White</cell><cell>64</cell><cell>68</cell><cell></cell></row><row><cell>Black</cell><cell>15</cell><cell>6.5</cell><cell></cell></row><row><cell>Asian</cell><cell>2.2</cell><cell>7.6</cell><cell></cell></row><row><cell>Hispanic</cell><cell>0.4</cell><cell>0.7</cell><cell></cell></row><row><cell>Other/unknown race/ethnicity, %</cell><cell>19</cell><cell>18</cell><cell></cell></row><row><cell>Year, %</cell><cell></cell><cell></cell><cell>0.008</cell></row><row><cell>1996-2003</cell><cell>49</cell><cell>58</cell><cell></cell></row><row><cell>2004-2010</cell><cell>51</cell><cell>43</cell><cell></cell></row><row><cell>ACS type, %</cell><cell></cell><cell></cell><cell>&lt;0.001</cell></row><row><cell>STEMI</cell><cell>34</cell><cell>21</cell><cell></cell></row><row><cell>NSTEMI</cell><cell>36</cell><cell>38</cell><cell></cell></row><row><cell>Unstable angina</cell><cell>30</cell><cell>42</cell><cell></cell></row><row><cell>Ever smoking, %</cell><cell>70</cell><cell>55</cell><cell>&lt;0.001</cell></row><row><cell>LDL cholesterol ≥160 mg/dl, %</cell><cell>13</cell><cell>13</cell><cell>0.95</cell></row><row><cell>HDL cholesterol &lt;40 mg/dl, %</cell><cell>59</cell><cell>40</cell><cell>&lt;0.001</cell></row><row><cell>Triglycerides ≥150 mg/dl, %</cell><cell>73</cell><cell>50</cell><cell>&lt;0.001</cell></row><row><cell>Statin use in prior year, %</cell><cell>35</cell><cell>38</cell><cell>0.29</cell></row><row><cell>Hypertension in prior year, %</cell><cell>53</cell><cell>72</cell><cell>&lt;0.001</cell></row><row><cell>History of diabetes, %</cell><cell>21</cell><cell>29</cell><cell>0.007</cell></row><row><cell>Recent CD4 cells/μL, %</cell><cell></cell><cell></cell><cell></cell></row><row><cell>&lt;200</cell><cell>20</cell><cell>-</cell><cell></cell></row><row><cell>200-499</cell><cell>47</cell><cell>-</cell><cell></cell></row><row><cell>≥500</cell><cell>31</cell><cell>-</cell><cell></cell></row><row><cell>Current antiretroviral therapy use, %</cell><cell>84</cell><cell></cell><cell></cell></row></table></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">HIV Med. Author manuscript; available in PMC 2020 January 01.</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>ACKNOWLEDGMENTS</head></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Author Manuscript</head></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Cause-specific life expectancies after 35 years of age for human immunodeficiency syndrome-infected and human immunodeficiency syndrome-negative individuals followed simultaneously in long-term cohort studies</title>
		<author>
			<persName><forename type="first">N</forename><surname>Wada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">P</forename><surname>Jacobson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Cohen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>French</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Phair</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Munoz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Epidemiol</title>
		<imprint>
			<biblScope unit="volume">177</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="116" to="125" />
			<date type="published" when="1984">1984-2008. 2013</date>
		</imprint>
	</monogr>
	<note>PubMed: 23287403</note>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Narrowing the gap in life expectancy between HIV-infected and HIV-uninfected individuals with access to care</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Marcus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">R</forename><surname>Chao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">A</forename><surname>Leyden</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Acquir Immune Defic Syndr</title>
		<imprint>
			<biblScope unit="volume">73</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="39" to="46" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note>PubMed: 27028501</note>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Coronary heart disease in HIV-infected individuals</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Currier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Taylor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Boyd</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Acquir Immune Defic Syndr</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="506" to="512" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
	<note>PubMed: 12869840</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">HIV infection and the risk of acute myocardial infarction</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Freiberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Chang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">H</forename><surname>Kuller</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">JAMA Intern Med</title>
		<imprint>
			<biblScope unit="volume">173</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="614" to="622" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>PubMed: 23459863</note>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Do protease inhibitors increase the risk for coronary heart disease in patients with HIV-1 infection?</title>
		<author>
			<persName><forename type="first">D</forename><surname>Klein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">B</forename><surname>Hurley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">P</forename><surname>Quesenberry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jr</forename><surname>Sidney</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Acquir Immune Defic Syndr</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="471" to="477" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
	<note>PubMed: 12154337</note>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Impact of individual antiretroviral drugs on the risk of myocardial infarction in human immunodeficiency virus-infected patients: a case-control study nested within the French Hospital Database on HIV ANRS cohort CO4</title>
		<author>
			<persName><forename type="first">S</forename><surname>Lang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mary-Krause</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Cotte</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arch Intern Med</title>
		<imprint>
			<biblScope unit="volume">170</biblScope>
			<biblScope unit="issue">14</biblScope>
			<biblScope unit="page" from="1228" to="1238" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note>PubMed: 20660842</note>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Immunodeficiency and risk of myocardial infarction among HIV-positive individuals with access to care</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Silverberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">A</forename><surname>Leyden</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Xu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Acquir Immune Defic Syndr</title>
		<imprint>
			<biblScope unit="volume">65</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="160" to="166" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note>PubMed: 24442222</note>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease</title>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">A</forename><surname>Triant</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Hadigan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Grinspoon</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Endocrinol Metab</title>
		<imprint>
			<biblScope unit="volume">92</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="2506" to="2512" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
	<note>PubMed: 17456578</note>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Increased Risk of Myocardial Infarction in HIV-Infected Individuals in North America Compared With the General Population</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Drozd</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Kitahata</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">N</forename><surname>Althoff</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Acquir Immune Defic Syndr</title>
		<imprint>
			<biblScope unit="volume">75</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="568" to="576" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note>PubMed: 28520615</note>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">The biology of atherosclerosis: general paradigms and distinct pathogenic mechanisms among HIV-infected patients</title>
		<author>
			<persName><forename type="first">J</forename><surname>Lo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Plutzky</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Infect Dis</title>
		<imprint>
			<biblScope unit="volume">205</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="S368" to="S374" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note>Suppl. PubMed: 22577210</note>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Risk of cardiovascular disease from antiretroviral therapy for HIV: a systematic review</title>
		<author>
			<persName><forename type="first">C</forename><surname>Bavinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Bendavid</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Niehaus</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page">e59551</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>PubMed: 23555704</note>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Class of antiretroviral drugs and the risk of myocardial infarction</title>
		<author>
			<persName><forename type="first">N</forename><surname>Friis-Moller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Reiss</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Sabin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">356</biblScope>
			<biblScope unit="issue">17</biblScope>
			<biblScope unit="page" from="1723" to="1735" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
	<note>PubMed: 17460226</note>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Cardiovascular risk and body-fat abnormalities in HIV-infected adults</title>
		<author>
			<persName><forename type="first">S</forename><surname>Grinspoon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Carr</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">352</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="48" to="62" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note>PubMed: 15635112</note>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Smoking among HIV positive New Yorkers: prevalence, frequency, and opportunities for cessation</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Tesoriero</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Gieryic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Carrascal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">E</forename><surname>Lavigne</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">AIDS Behav</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="824" to="835" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note>PubMed: 18777131</note>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Declining Relative Risk for Myocardial Infarction Among HIV-Positive Compared with HIV-Negative Individuals with Access to Care</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">B</forename><surname>Klein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">A</forename><surname>Leyden</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Xu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Infect Dis</title>
		<imprint>
			<biblScope unit="volume">60</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="1278" to="1280" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note>PubMed: 25595743</note>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Clinical features of acute coronary syndromes in patients with human immunodeficiency virus infection</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">Y</forename><surname>Hsue</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Giri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Erickson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<imprint>
			<biblScope unit="volume">109</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="316" to="319" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
	<note>PubMed: 14718406</note>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Acute myocardial infarction in human immunodeficiency virus-infected patients</title>
		<author>
			<persName><forename type="first">S</forename><surname>Matetzky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Domingo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kar</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arch Intern Med</title>
		<imprint>
			<biblScope unit="volume">163</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="457" to="460" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
	<note>PubMed: 12588205</note>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Acute coronary syndrome in human immunodeficiency virus-infected patients: characteristics and 1 year prognosis</title>
		<author>
			<persName><forename type="first">F</forename><surname>Boccara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mary-Krause</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Teiger</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur Heart J</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="41" to="50" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note>PubMed: 20965887</note>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Increased mortality after a first myocardial infarction in human immunodeficiency virus-infected patients; a nested cohort study</title>
		<author>
			<persName><forename type="first">D</forename><surname>Carballo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Delhumeau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Carballo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">AIDS Res Ther</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="issue">4</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note>PubMed: 25705241</note>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Mortality and Health Service Use Following Acute Myocardial Infarction Among Persons with HIV: A Population-Based Study</title>
		<author>
			<persName><forename type="first">C</forename><surname>Jeon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Lau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">E</forename><surname>Kendall</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">AIDS Res Hum Retroviruses</title>
		<imprint>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note>Epub ahead of print</note>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Clinical presentation of acute coronary syndrome in HIV infected adults: a retrospective analysis of a prospectively collected cohort</title>
		<author>
			<persName><forename type="first">R</forename><surname>Perello</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Calvo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Miro</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Intern Med</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="485" to="488" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note>PubMed: 21925057</note>
</biblStruct>

<biblStruct xml:id="b21">
	<monogr>
		<title level="m" type="main">Similarity of the Adult Kaiser Permanente Membership in Northern California to the Insured and General Population in Northern California: Statistics from the 2011 California Health Interview Survey</title>
		<author>
			<persName><forename type="first">N</forename><surname>Gordon</surname></persName>
		</author>
		<ptr target="https://divisionofresearch.kaiserpermanente.org/projects/memberhealthsurvey/SiteCollectionDocuments/chis_non_kp_2011.pdf" />
		<imprint>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Population trends in the incidence and outcomes of acute myocardial infarction</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">W</forename><surname>Yeh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Sidney</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Chandra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Sorel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">V</forename><surname>Selby</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Go</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">362</biblScope>
			<biblScope unit="issue">23</biblScope>
			<biblScope unit="page" from="2155" to="2165" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note>PubMed: 20558366</note>
</biblStruct>

<biblStruct xml:id="b23">
	<monogr>
		<title level="m" type="main">Vital Records Data and Statistics. California Department of Public Health</title>
		<ptr target="https://www.cdph.ca.gov/Programs/CHSI/Pages/Data-and-Statistics-.aspx" />
		<imprint>
			<date type="published" when="2018-01-04">2018. January 4. 2018</date>
		</imprint>
	</monogr>
	<note>updated</note>
</biblStruct>

<biblStruct xml:id="b24">
	<monogr>
		<title level="m" type="main">Death Master File Monthly Updates. National Technical Information Service</title>
		<ptr target="https://dmf.ntis.gov/monthly/" />
		<imprint>
			<date type="published" when="2016">2016</date>
			<pubPlace>U.S. Department of Commerce</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Ethnic disparities in diabetic complications in an insured population</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Karter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ferrara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">Y</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">H</forename><surname>Moffet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Ackerson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">V</forename><surname>Selby</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Jama</title>
		<imprint>
			<biblScope unit="volume">287</biblScope>
			<biblScope unit="issue">19</biblScope>
			<biblScope unit="page" from="2519" to="2527" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
	<note>PubMed: 12020332</note>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Outcomes after acute myocardial infarction in HIV-infected patients: analysis of data from a French nationwide hospital medical information database</title>
		<author>
			<persName><forename type="first">L</forename><surname>Lorgis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Cottenet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Molins</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<imprint>
			<biblScope unit="volume">127</biblScope>
			<biblScope unit="issue">17</biblScope>
			<biblScope unit="page" from="1767" to="1774" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>PubMed: 23543004</note>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Differences between HIV-infected and uninfected adults in the contributions of smoking, diabetes and hypertension to acute coronary syndrome: two parallel case-control studies</title>
		<author>
			<persName><forename type="first">M</forename><surname>Calvo-Sanchez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Perello</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Perez</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">HIV Med</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="40" to="48" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>PubMed: 23088307</note>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Association of immunologic and virologic factors with myocardial infarction rates in a US healthcare system</title>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">A</forename><surname>Triant</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Regan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">E</forename><surname>Sax</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Meigs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Grinspoon</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Acquir Immune Defic Syndr</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="615" to="619" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note>PubMed: 20827215</note>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Low CD4+ T cell count is a risk factor for cardiovascular disease events in the HIV outpatient study</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Lichtenstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Armon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Buchacz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Infect Dis</title>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="435" to="447" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note>PubMed: 20597691</note>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">HIV replication and immune status are independent predictors of the risk of myocardial infarction in HIV-infected individuals</title>
		<author>
			<persName><forename type="first">S</forename><surname>Lang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mary-Krause</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Simon</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Infect Dis</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="600" to="607" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note>PubMed: 22610928</note>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Lessons learned from the design and implementation of myocardial infarction adjudication tailored for HIV clinical cohorts</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">M</forename><surname>Crane</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Heckbert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Drozd</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Epidemiol</title>
		<imprint>
			<biblScope unit="volume">179</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="996" to="1005" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note>PubMed: 24618065</note>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Influence of Human Immunodeficiency Virus Seropositive Status on the In-Hospital Management and Outcomes of Patients Presenting With Acute Myocardial Infarction</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">R</forename><surname>Smilowitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Gupta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Guo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">T</forename><surname>Coppola</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Bangalore</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Invasive Cardiol</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="403" to="409" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note>PubMed: 27705890</note>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title/>
		<ptr target="https://www.cdph.ca.gov/Programs/CID/DOA/CDPH%20Document%20Library/California%20HIV%20Surveillance%20Report%20-%202014_ADA.pdf" />
	</analytic>
	<monogr>
		<title level="j">California HIV Surveillance Report</title>
		<imprint/>
		<respStmt>
			<orgName>California Department of Public Health</orgName>
		</respStmt>
	</monogr>
	<note>Office of AIDS</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
